| MRKR Stock | | | USD 1.72 0.02 1.18% |
Marker Therapeutics financial indicator trend analysis is infinitely more than just investigating Marker Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Marker Therapeutics is a good investment. Please check the relationship between Marker Therapeutics Net Working Capital and its Accounts Payable accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marker Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
To learn how to invest in Marker Stock, please use our
How to Invest in Marker Therapeutics guide.
Net Working Capital vs Accounts Payable
Net Working Capital vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Marker Therapeutics Net Working Capital account and
Accounts Payable. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Marker Therapeutics' Net Working Capital and Accounts Payable is 0.4. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Marker Therapeutics, assuming nothing else is changed. The correlation between historical values of Marker Therapeutics' Net Working Capital and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Marker Therapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Working Capital i.e., Marker Therapeutics' Net Working Capital and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.4 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Net Working Capital
Accounts Payable
An accounting item on the balance sheet that represents Marker Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Marker Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Marker Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Marker Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marker Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
To learn how to invest in Marker Stock, please use our
How to Invest in Marker Therapeutics guide.At this time, Marker Therapeutics'
Tax Provision is relatively stable compared to the past year. As of 02/16/2025,
Enterprise Value is likely to grow to about 27.1
M, while
Selling General Administrative is likely to drop slightly above 5.6
M.
Marker Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Marker Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Marker Therapeutics fundamental ratios Accounts
Additional Tools for Marker Stock Analysis
When running Marker Therapeutics' price analysis, check to
measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.